SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Inpex Corporation (IPXHY) trades at a trailing P/E of 0.1. Trailing earnings yield is 1,250.00%. PEG 0.16 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.16); earnings yield beats bond yields (1,250.00%).
- PEG Ratio 0.16 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1,250.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 72/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IPXHY
Valuation Multiples
P/E (TTM)0.1
Forward P/EN/A
PEG Ratio0.16
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$346.64
Book Value / Share$0.00
Revenue / Share$1,770.05
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1,250.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$31.61 |
$874.42B |
$46.17B |
5.3% |
| 2017 |
$27.64 |
$933.7B |
$40.36B |
4.3% |
| 2018 |
$65.81 |
$971.39B |
$96.11B |
9.9% |
| 2019 |
$112.82 |
$1.33T |
$164.73B |
12.4% |
| 2020 |
$-71.09 |
$771.05B |
$-103.81B |
-13.5% |
| 2021 |
$153.87 |
$1.24T |
$223.05B |
17.9% |
| 2022 |
$364.57 |
$2.32T |
$461.07B |
19.8% |
| 2023 |
$286.85 |
$2.16T |
$321.71B |
14.9% |
| 2024 |
$345.07 |
$2.27T |
$427.34B |
18.9% |
| 2025 |
$346.64 |
$2.11T |
$412.93B |
19.6% |
